BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37396735)

  • 1. Role of Serum Ferritin, D-Dimer, and C-Reactive Protein Parameters in COVID 19 Severity.
    Abdullateef Abdullah Z; Fouad Ali L
    Arch Razi Inst; 2023 Apr; 78(2):737-742. PubMed ID: 37396735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analyzing Correlation of Clinical Severity of COVID-19 with Other Biochemical Parameters: A Retrospective Study from Pakistan.
    Hassan Shah SST; Naeem I; Wahid B
    Tohoku J Exp Med; 2021 Dec; 255(4):315-323. PubMed ID: 34911879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of D-Dimer, C-Reactive Protein, and Ferritin with COVID-19 Severity in Pregnant Women: Important Findings of a Cross-Sectional Study in Northern Brazil.
    Paixão JTR; Santos CJSE; França APFM; Lima SS; Laurentino RV; Fonseca RRS; Vallinoto ACR; Oliveira-Filho AB; Machado LFA
    Int J Environ Res Public Health; 2023 Jul; 20(14):. PubMed ID: 37510647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Analytical Values D-Dimer, Glucose, Ferritin and C-Reactive Protein of Symptomatic and Asymptomatic COVID-19 Patients.
    Pérez-García N; García-González J; Requena-Mullor M; Rodríguez-Maresca MÁ; Alarcón-Rodríguez R
    Int J Environ Res Public Health; 2022 Apr; 19(9):. PubMed ID: 35564749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory Response in COVID-19 Depending on the Severity of the Disease and the Vaccination Status.
    Trofin F; Nastase EV; Roșu MF; Bădescu AC; Buzilă ER; Miftode EG; Manciuc DC; Dorneanu OS
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hematological Parameters in COVID-19 Patients: Association with Severity of the Disease.
    Abdulla AA; Abdulaali Abed T; Fadhel Abbas Awadh E
    Arch Razi Inst; 2022 Dec; 77(6):2415-2421. PubMed ID: 37274917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of laboratory parameters in predicting severity of COVID-19 disease in pregnant patients.
    Sahin O; Aktoz F; Bagci H; Vurgun E
    J Obstet Gynaecol; 2022 Aug; 42(6):1917-1921. PubMed ID: 35603633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Covid-19 with blood type A in relation to blood sugar, urea, and blood test (D-dimer and ferritin) in patients from Al-Najaf.
    Hussein HJ; Ibrahim SA; Al-Shaibani SW; Abdulrudha NH
    J Med Life; 2022 Feb; 15(2):180-187. PubMed ID: 35419105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of COVID-19 disease severity in patients with underlying rheumatic disease.
    Santos CS; Morales CM; Álvarez ED; Castro CÁ; Robles AL; Sandoval TP
    Clin Rheumatol; 2020 Sep; 39(9):2789-2796. PubMed ID: 32720259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of clinically relevant serum proteins as biomarkers for monitoring COVID-19 severity, and end-organ damage among hospitalized unvaccinated patients.
    Elhommosani MR; Sakr MM; Abbas RM; Aboshanab KM
    BMC Infect Dis; 2024 Feb; 24(1):231. PubMed ID: 38378528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 severity appears to be reduced in spring/summer.
    Sposato B; Serafini A; Simoncini E; Croci L; Guidoni C; Scalese M; Baratta P; Cresti A; Lacerenza LG; Lena F; Nencioni C; Spargi G; Perrella A;
    Epidemiol Prev; 2023; 47(1-2):34-46. PubMed ID: 36971236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basic Predictive Risk Factors for Cytokine Storms in COVID-19 Patients.
    Shcherbak SG; Anisenkova AY; Mosenko SV; Glotov OS; Chernov AN; Apalko SV; Urazov SP; Garbuzov EY; Khobotnikov DN; Klitsenko OA; Minina EM; Asaulenko ZP
    Front Immunol; 2021; 12():745515. PubMed ID: 34858403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coagulation profile and correlation between D-dimer, inflammatory markers, and COVID-19 severity in an Indonesian national referral hospital.
    Sukrisman L; Sinto R
    J Int Med Res; 2021 Nov; 49(11):3000605211059939. PubMed ID: 34796762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enoxaparin Effect on Interleukin-10 Levels in Iraqi Patients with COVID-19: A Case-Control Study.
    Al-Hashimi NH; Al-Hindawi MS; Mohsen AM; Al-Gebori AM
    Front Biosci (Schol Ed); 2024 Apr; 16(2):9. PubMed ID: 38939974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secretory Phospholipase A2 and Interleukin-6 Levels as Predictive Markers of the Severity and Outcome of Patients with COVID-19 Infections.
    Urazov S; Chernov A; Popov O; Klenkova N; Sushentseva N; Polkovnikova I; Apalko S; Kislyuk K; Pavlovich D; Ivanov A; Shcherbak S
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mortality in Patients of COVID-19 Infection: Biochemical Markers and its Cut-off Values for Predicting Outcome.
    Yousaf MN; Sarwar S; Tarique S; Ahmed M; Tahir H
    J Coll Physicians Surg Pak; 2022 Jan; 32(1):37-41. PubMed ID: 34983145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The predictive and prognostic role of hematologic and biochemical parameters in the emergency department among coronavirus disease 2019 patients.
    Huang CY; Tsai HW; Liu CY; Liu TH; Huang HL; Chang CC; Chen WC; Sun JT
    Chin J Physiol; 2021; 64(6):306-311. PubMed ID: 34975124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of electrolyte imbalances in predicting the severity of COVID-19 in the hospitalized patients: a cross-sectional study.
    Yasari F; Akbarian M; Abedini A; Vasheghani M
    Sci Rep; 2022 Aug; 12(1):14732. PubMed ID: 36042344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Inflammatory Markers With Disease Progression and the Severity of COVID-19.
    Patel SV; Pathak JM; Parikh RJ; Pandya KJ; Kothari PB; Patel A
    Cureus; 2024 Feb; 16(2):e54840. PubMed ID: 38533136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of some hematological parameters between male and female patients infected with COVID-19.
    Abed HH; Al-Ziaydi AG; Taher IA; Al Dulaimi AK
    Hum Antibodies; 2022; 30(3):151-155. PubMed ID: 35786649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.